OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CCNYSE67

Chemours Co

Diversified ChemicalsVerified

The Chemours Company has a debt-to-equity ratio of 16.4, indicating a high level of leverage, and a current ratio of 1.78, suggesting moderate short-term liquidity. The company's free cash flow for FY2025 was $51 million, which is significantly lower than its capital expenditure of $213 million, indicating a cash outflow for investment. The return on equity is negative at -1.544, and the return on assets is also negative at -0.0523, reflecting poor profitability and asset utilization. The company's profitability is below the industry median for key metrics such as return on equity and return on assets. The negative net income of $386 million for FY2025 highlights the company's current financial challenges. The company's gross profit margin is 15.4%, which is lower than the industry median, indicating that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated across three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The company serves over 2,700 customers in approximately 110 countries, indicating a global presence. However, the company's revenue concentration in specific markets and segments could expose it to regional or sector-specific risks. The company's revenue for FY2025 was $5.81 billion, and the outlook for the current fiscal year is for a decline in revenue. The company's growth trajectory is constrained by factors such as fluctuations in energy and raw materials pricing, increased competition, and regulatory requirements. The company's capital expenditure is expected to remain high, which could further impact its free cash flow. The company faces several risk factors, including significant litigation and environmental matters, global economic and capital markets conditions, and business or supply disruptions. The risk assessment indicates a medium level of liquidity and dilution risk. The company's dilution potential is moderate, and the risk assessment cites potential dilution from offerings or other financing activities. The company's adjustments to its valuations reflect the impact of these risks on its financial performance. Recent events, including the interim consolidated financial statements for the nine months ended September 30, 2025, show a net loss of $324 million and a significant decrease in cash and cash equivalents. The company's liquidity is supported by future cash flows from operations and its revolving credit facility, but adverse legal or environmental matters could impact its liquidity. The company's filings also highlight the importance of managing capital projects and the potential for goodwill impairment.

30-day price · CC+6.20 (+34.8%)
Low$17.40High$28.67Close$24.01As of15 May, 00:00 UTC
Profile
CompanyChemours Co
ExchangeNYSE
TickerCC
CIK0001627223
SICChemicals & Allied Products
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. The Chemours Company provides industrial and specialty chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The company operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials.

Classification. The Chemours Company is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

The Chemours Company has a debt-to-equity ratio of 16.4, indicating a high level of leverage, and a current ratio of 1.78, suggesting moderate short-term liquidity. The company's free cash flow for FY2025 was $51 million, which is significantly lower than its capital expenditure of $213 million, indicating a cash outflow for investment. The return on equity is negative at -1.544, and the return on assets is also negative at -0.0523, reflecting poor profitability and asset utilization. The company's profitability is below the industry median for key metrics such as return on equity and return on assets. The negative net income of $386 million for FY2025 highlights the company's current financial challenges. The company's gross profit margin is 15.4%, which is lower than the industry median, indicating that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated across three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The company serves over 2,700 customers in approximately 110 countries, indicating a global presence. However, the company's revenue concentration in specific markets and segments could expose it to regional or sector-specific risks. The company's revenue for FY2025 was $5.81 billion, and the outlook for the current fiscal year is for a decline in revenue. The company's growth trajectory is constrained by factors such as fluctuations in energy and raw materials pricing, increased competition, and regulatory requirements. The company's capital expenditure is expected to remain high, which could further impact its free cash flow. The company faces several risk factors, including significant litigation and environmental matters, global economic and capital markets conditions, and business or supply disruptions. The risk assessment indicates a medium level of liquidity and dilution risk. The company's dilution potential is moderate, and the risk assessment cites potential dilution from offerings or other financing activities. The company's adjustments to its valuations reflect the impact of these risks on its financial performance. Recent events, including the interim consolidated financial statements for the nine months ended September 30, 2025, show a net loss of $324 million and a significant decrease in cash and cash equivalents. The company's liquidity is supported by future cash flows from operations and its revolving credit facility, but adverse legal or environmental matters could impact its liquidity. The company's filings also highlight the importance of managing capital projects and the potential for goodwill impairment.
Key takeaways
  • The Chemours Company has a high debt-to-equity ratio and a negative return on equity, indicating significant financial leverage and poor profitability.
  • The company's revenue is concentrated across three segments, and its global presence could expose it to regional or sector-specific risks.
  • The company's growth trajectory is constrained by factors such as cost pressures, increased competition, and regulatory requirements.
  • The company faces significant risk factors, including litigation, environmental matters, and business or supply disruptions, which could impact its liquidity and financial performance.
  • # RATIONALES
  • ```json
  • {
  • "margin_outlook_rationale": "The company's gross profit margin is expected to remain under pressure due to cost and pricing challenges.",
Financial snapshot
PeriodFY2025
CurrencyUSD
Revenue$5.81B
Gross profit$902.0M
Operating income
Net income-$386.0M
R&D$108.0M
SG&A
D&A$340.0M
SBC$21.0M
Operating cash flow$264.0M
CapEx$213.0M
Free cash flow$51.0M
Total assets$7.38B
Total liabilities$7.13B
Total equity$250.0M
Cash & equivalents$670.0M
Long-term debt$4.10B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$5.81B-$386.0M$51.0M
FY2025$1.50B-$339.0M
FY2025$1.61B-$380.0M
FY2025$1.37B-$5.0M
FY2024$5.78B$86.0M-$993.0M
PeriodGross %Op %Net %FCF %
FY2025
FY2025
FY2025
FY2025
FY2024
PeriodAssetsEquityCashDebt
FY2025$7.38B$250.0M$670.0M
FY2025$7.55B$274.0M
FY2025$7.46B$228.0M
FY2025$7.38B$566.0M
FY2024$7.51B$604.0M$713.0M
PeriodOCFCapExFCFSBC
FY2025$264.0M$213.0M$51.0M$21.0M
FY2025$127.0M
FY2025-$19.0M
FY2025-$112.0M
FY2024-$633.0M$360.0M-$993.0M$15.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q3 2025$4.48B-$325.0M-$41.0M
Q2 2025$2.98B-$385.0M-$146.0M
Q3 2025
Q1 2025$1.37B-$4.0M-$196.0M
PeriodGross %Op %Net %FCF %
Q3 2025
Q2 2025
Q3 2025
Q1 2025
PeriodAssetsEquityCashDebt
Q3 2025$7.57B$298.0M$613.0M
Q2 2025$7.49B$237.0M$502.0M
Q3 2025$239.0M
Q1 2025$7.39B$579.0M$464.0M
PeriodOCFCapExFCFSBC
Q3 2025$127.0M$168.0M-$41.0M$17.0M
Q2 2025-$19.0M$127.0M-$146.0M$12.0M
Q3 2025
Q1 2025-$112.0M$84.0M-$196.0M$5.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$203.0M
Net cash-$3.43B
Current ratio1.8
Debt/Equity16.4
ROA-5.2%
ROE-1.5%
Cash conversion-68.0%
CapEx/Revenue3.7%
SBC/Revenue0.4%
Asset intensity0.4
Dilution ratio0.2%
Risk assessment
Dilution riskMedium
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricCCActivity
Op margin-1.1% medp25 -1.1% · p75 -1.1%
Net margin-6.6%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin15.5%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9%1.9% medp25 1.9% · p75 1.9%top quartile
CapEx / revenue3.7%-7.1% medp25 -12.7% · p75 -4.4%top quartile
Debt / equity1640.0%1639.6% medp25 1639.6% · p75 1639.6%top quartile
Observations
IR observations
market data ESG controversies score1.2
market data ESG governance pillar89.5
market data ESG social pillar74.7
market data insider trading score4.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001627223 · 492 us-gaap concepts
2026-05-01 15:09 UTC#68c7bb5a
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 15:11 UTCJob: 1cfc78dd